Senthil H, Streilein S, Whiteside T, Minuk L, et al. Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review. Haematologica 2025 Oct 9. doi: 10.3324/haematol.2025.288780.
PMID: 41063693